Home Up Mail an Joachim Pimiskern Impressum

Multiple Sklerose und Antikörper / Multiple Sclerosis and Antibodies


7.5.2007

http://www.eurekalert.org/pub_releases/2007-05/aaon-ssi_1041007.php
Studies suggest investigational agent reduces disease activity in MS
rituximab Multiple Sklerose, antibody, B-Cells
22.3.2009

http://www.eurekalert.org/pub_releases/2007-07/wuso-alt062907.php
Antibody linked to MS significantly higher in spinal fluid of blacks
multiple sclerosis diagnostic marker IgG
12.10.2007

http://www.aerzteblatt.de/v4/news/news.asp?id=30105
Medizin: Multiple Sklerose: Antikörper reparieren Myelin im Tiermodell
Sklerose rHIgM22
15.9.2007

http://idw-online.de/pages/de/news225109
Antikörper attackieren Nervenfasern - Möglicher Mechanismus der Multiplen Sklerose entdeckt
NF-186, NF-155
15.9.2007

http://www.scienceticker.info/2007/09/11/ms-antikoerper-attackieren-nervenfasern/
MS: Antikörper attackieren Nervenfasern
Multiple-Sklerose Neurofascin-Antikörper
16.2.2010

http://www.eurekalert.org/pub_releases/2010-02/uouh-ptf021610.php
Promising therapy for relapsing multiple sclerosis
relapsing CD25 daclizumab
8.1.2007

http://www.uni-protokolle.de/nachrichten/id/130160/
Uni-Klinik Düsseldorf: Entdeckung krankmachender Autoantikörper bei Multipler Sklerose
Autoantigen MOG (Myelin Oligodendrozyten Glycoprotein)
8.1.2007

http://idw-online.de/pages/de/news191080
Uni-Klinik Düsseldorf: Entdeckung krankmachender Autoantikörper bei Multipler Sklerose
Autoantikörper, Autoantigen MOG (Myelin Oligodendrozyten Glycoprotein)
3.3.2008

http://www.uphs.upenn.edu/news/News_Releases/apr07/ms-drug-vision.html
MS Treatment Also Reduces Vision Loss
multiple sclerosis natalizumab
30.10.2008

http://www.newscientist.com/channel/health/dn15023-drug-reboots-immune-system-to-reverse-ms.html
Drug reboots immune system to reverse MS
multiple sclerosis, alemtuzumab, Reboot-des-Immunsystems
9.12.2007

http://www.eurekalert.org/pub_releases/2007-04/uops-prf041207.php
Penn researchers find treatment for MS also reduces vision loss in MS patients
natalizumab Multiple-Sklerose